According to our colleagues at Kalorama Information, it is an exciting and interesting time to be involved in the nearly $4 billion cell and gene therapy industry. The science is moving ahead and now the industry needs to industrialize and standardize the manufacturing and commercialization of products. The industry is moving in the direction of […]
Market Research
The latest report from SDi examines the bioprocessing market which they project will grow at a compound annual growth rate (CAGR) of 9.0% during the next five years. The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. […]
The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.
More than 3,000 scientists have now participated in our ongoing tracking survey about the status of their labs and the impact COVID-19 is having on their research. These scientists have shared with us the affect on their lab’s operations, the actions taken by their organizations in response to the pandemic, how they anticipate their lab […]
The chromatography market includes both gas and liquid separation techniques. All chromatography instruments incorporate the following: a sample-introduction port of some type; a delivery system for a mobile phase carrier which moves the sample through the system; a stationary phase, which may be held within a column, a capillary and one or more detectors that […]
Sample preparation refers to the ways in which a sample is treated prior to its analyses. At first glance, sample preparation may seem like the most routine aspect of an analytical protocol. However, it is critical to remember that any test result is only as good as the sample preparation that has preceded it. As […]
Politico reported today that CDC Director Robert Redfield said on Tuesday that he is not confident that U.S. labs have an adequate stock of the supplies used to extract genetic material from any virus in a patient’s sample — a critical step in coronavirus testing. The article goes on to quote Michael Mina, MD, PhD […]
It’s been another busy and exciting year here at BioInformatics, now part of Science and Medicine Group. Together with our sister brands, Instrument Business Outlook, IMV Medical Information, Kalorama Information and Strategic Directions International, we’ve been helping clients achieve success through our quantitative and qualitative custom research services, our market research reports and industry data […]
According to SDi’s recent publication, The 2019 Market for Live Cell Imaging, the total market for live cell imaging instruments, assays, and labeling reagents is projected to reach $1.9 billion in five years with a CAGR of 7.3%. Among the factors driving this high growth is the increasing adoption of advanced microscopy techniques for live […]
BioInformatics Inc., part of Science and Medicine Group, the leading research and advisory firm serving the life science tools market, announced the winners of the Life Science Industry Awards for the most innovative new products in 2019. Here are the 2019 Winners of the Life Science Industry Awards – Innovation: Most Innovative New […]
Pay Invoice
Latest Blogs
-
Assessing the Value of Product Attributes: Deciphering Consumer Preferences
April 25, 2024 10:28 am
-
How Market Research Supercharges Life Sciences Go-To-Market Strategies
April 24, 2024 12:34 pm
-
4 Key Components to a Winning Go-To-Market Strategy
April 24, 2024 12:28 pm
Sitemap
Your Data and Privacy
About Us
BioInformatics, part of the Science and Medicine Group, is the leading research and advisory firm serving the life science and diagnostic industries. Our expertise includes primary quantitative and qualitative research in addition to secondary research and published reports. We own a proprietary, international community of more than 55,000 scientists and biomedical researchers to provide insights that grow businesses and move markets. Our multi-disciplinary team is comprised of industry veterans, market research experts, and survey statisticians.